US Trade Barriers Report Signals Work Ahead 02/04/2012 by Intellectual Property Watch Leave a Comment The annual US list of barriers to trade in other countries was published today, with profiles of dozens of trading partners from very large to very small.
Second Annual US IP Enforcement Report Shows Extensive Efforts At Home And Abroad 02/04/2012 by William New, Intellectual Property Watch Leave a Comment The second annual report of the Office of the Intellectual Property Enforcement Coordinator (IPEC) Victoria Espinel paints a picture of the United States’ multifaceted and ever-expanding war on IP infringement, at home and abroad.
Book Details IP Rights And Development 02/04/2012 by Intellectual Property Watch Leave a Comment Using on-the-ground research in Africa and the Netherlands, the authors of a recent book looked at the impact of intellectual property on agriculture and health in developing countries. The study made some surprise findings in relation to IP and development, such as IP-related obstacles to knowledge and technology transfer.
WHO / EU “Bad Medicine” Plans: Flaws, Coordination Gaps 02/04/2012 by Intellectual Property Watch 2 Comments The latest World Health Organization / European Union plans to counter the trade in counterfeit and substandard medicines aim to ensure that medicines in the developing world are safe. As such, though both plans appropriately address quality issues, they fall short of adequate coordination and collaboration with each other, and also present substantial flaws, Daniele Dionisio writes.
Novartis India Challenge Postponed To July 28/03/2012 by Intellectual Property Watch 2 Comments The Indian Supreme Court today postponed hearing the high-profile case involving Swiss pharmaceutical producer Novartis’ challenge of India’s patent law until July, according to sources.
European Parliament Rejects Referral Of ACTA To EU High Court 27/03/2012 by Monika Ermert for Intellectual Property Watch 2 Comments The Committee of International Trade of the European Parliament today voted against referring the Anti-Counterfeiting Trade Agreement (ACTA) to the European Court of Justice (ECJ).
US Supreme Court Reverses Myriad Decision Allowing Gene Patents 27/03/2012 by Intellectual Property Watch 1 Comment The United States Supreme Court yesterday threw out a high-profile case that had allowed a private company’s patents on two human genes associated with cancer.
Global Fund Changes Continue As West Africa Team Leader Departs 23/03/2012 by William New, Intellectual Property Watch 1 Comment The head of the West Africa region for the Global Fund to Fight AIDS, Tuberculosis and Malaria is the next in the line of departures under the organisation’s reforms. On the way out, he sent around a passionate farewell email calling for a dedication to values, and offering a small window on the wrenching transition taking place inside the international organisation.
UK Parliament Group Conducts Post-Hargreaves Inquiry Into IP Policy 22/03/2012 by Maricel Estavillo for Intellectual Property Watch 1 Comment The All-Party Parliamentary Intellectual Property Group in the United Kingdom is undertaking an inquiry into the government’s role in intellectual property (IP) promotion and protection, less than a year after the publication of an independent and comprehensive review on the UK’s IP system.
US Supreme Court Narrows Patentable Subject Matter 21/03/2012 by Intellectual Property Watch 3 Comments On 20 March, the US Supreme Court cut back on the types of inventions that can be patented in America. The court held in Mayo Collaborative Services v. Prometheus Labs., Inc. that one cannot patent an invention which merely applies known technology to natural phenomena.